BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

July 24, 2020 Leave a comment 783 Views

BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NurOwn®

BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

COVID-19 and extracellular vesicles – an intriguing interplay

Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy

Upcoming Webinar – Ferrohydrodynamic isolation of circulating tumor cells and exosomes

Plasmonic olocrimetric biosensor for sensitive exosome detection

Development of a simple, sensitive and selective colorimetric aptasensor for the detection of cancer-derived exosomes

miR Scientific announces FDA breakthrough device designation for its prostate cancer liquid biopsy test